Alyce Mei-Shiuan Kuo

5PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 09, 2024
Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel.

Megan H Trager, Alyce M Kuo, Stephen W Dusza

|Jun 03, 2023
Management of immune-related cutaneous adverse events with dupilumab.

Alyce Mei-Shiuan Kuo, Stephanie Gu, Joseph Stoll

|Jun 24, 2022
Contribution of the Skin-Gut Axis to Immune-Related Adverse Events with Multi-System Involvement.

Alyce M Kuo, Lukas Kraehenbuehl, Stephanie King

|May 09, 2022
Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma.

Alyce M Kuo, Hani Hassoun, Urvi Shah

|May 16, 2020
Self-Reported Prevalence of Allergies in the USA and Impact on Skin-An Epidemiological Study on a Representative Sample of American Adults.

Sophie Seité, Alyce Mei-Shiuan Kuo, Charles Taieb

Pageof 1

Frequent Collaborators

1 joint publications

Heather J Landau

1 joint publications

Alexander M Lesokhin

1 joint publications

Alina Markova

1 joint publications

Lukas Kraehenbuehl